DAFTAR RUJUKAN

1. Mills SE. Sternbergs diagnostic surgical pathology: the prostate and seminal vesicles. Philadelphia: Lippincott Williams & Wilkins, 2004: 2089-2115. 2. Raphael R, Strayer DS. Rubins pathology: clinicopathologic foundations of medicine. Philadelphia: Lippincott Williams & Wilkins, 2008: 773-778. 3. Pusat data dan informasi PERSI. Kanker prostat. 2004 [cited 2010 Jan 19]. Available from: http://www.pdpersi.co.id/?show=detailnews&kode=927&tbl=artikel. 4. Hammerich KH, Ayala GE, Wheeler TM. Anatomy of the prostate gland and surgical pathology of prostate cancer. Cambrige University Press, 2009: 110. 5. Chandrasoma P, Taylor CR. Concise pathology: testicular neoplasm. United State: Mc.Graw-Hill, 2001: 756-760. 6. Eroschenko VP. Atlas histologi di Fiore dengan korelasi fungsional. Jakarta: EGC, 2001: 288-289. 7. Theodorescu D, Krupski TL. Prostate cancer - biology, diagnosis, pathology, staging, and natural history. 2009 [cited 2010 Jan 20]. Available from: http://emedicine.medscape.com/article/458011-overview. 8. Stevens A, Lowe J. Pathology: prostate gland. 2nd ed. London: Mosby, 2000: 390-392. 9. Kumar V, Abbas AK, Fausto N. Pathologic basis of disease: prostate. Philadelphia: Elsevier Saunders, 2005: 1050-1056. 10. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. Pathology and genetics tumours of the urinary system and male genital organs: acinar adenocarcinoma. Lyon: IARC Press, 2004: 162-192. 11. Mikuz G. Clinical pathology of urologic tumors. London: Informa Healthcare, 2007: 100-130. 12. Zhou M, Galluzi CM. Genitourinary pathology: neoplasms of the prostate and seminal vesicles. Philadelphia: Elsevier, 2007: 56-84. 13. Weinberg R, Shay J, Liotta L. The cancer handbook: male genital tract. USA: Huangziman, 2003: 655-674. 14. Gerry J, Veltri RW, Miller MC,Strum SB. The Gleason score: a significant biologic manifestation of prostate cancer aggressiveness on biopsy. 2001 [cited 2010 Jan 20]. Available from:http://www.prostatecancer.org/education/staging/Dowd_GleasonScore. 15. Rosai J. Rosai and Ackermans surgical pathology: male reproductive system. Volume one. Philadelphia: Mosby, 2004: 1376-1384. 16. Tannenbaum M, Madden JF. Diagnostic atlas of genitourinary pathology: testis. Philadelphia: Elsevier, 2006: 165-173.

Universitas Sumatera Utara

17. Cramer SD. Prostate cancer. New York: Chelsea House, 2007: 12-102. 18. Pilarski R. Prostate cancer. 2006 [cited 2010 Jan 28]. Available from: http://id.articlesnatch.com/Article/Prostate-Cancer/44385. 19. Dabbs DJ. Diagnostic immunohistochemistry: immunohistology of the prostate, bladder, testis and kidney. 2nd ed. Philadelphia: Elseviers, 2006: 509-534. 20. Miller RT. The focus immunohistochemistry: immunohistochemical markers of prostate carcinoma. Propath, 2005: 1-2. 21. Schlomm T, et.al. Clinical significance of p53 alterations in surgically treated prostate cancers. Modern Pathology, 2008; 21: 1371-1378. 22. Leite KRM, Srougi M, Nesralhah LJ, Camara-Lopes LH. Analysis of p53 expression and proliferative assessment using PCNA in localized prostate carcinoma. Brazilian Journal of Medical and Biological Research ,1999; 32: 283-288. 23. Petrescu A, Mrzan L, Codreanu O, Niculescu L. Immunohistochemical detection of p53 protein as a prognostic indicator in prostate carcinoma. RJME, 2006; 47(2): 143-146. 24. DeVita VT, Hellman S, Rosenberg SA. Principles and practise of oncology: cancer of the prostate. 7th ed. Philadelphia: Lippincott Williams and Wilkins, 2005: 1192-1198. 25. Chang C. Prostate Cancer: basic mechanisms and therapeutic approaches. Singapore: World Scientific, 2005: 55-68.

Universitas Sumatera Utara